XML 25 R16.htm IDEA: XBRL DOCUMENT
v3.23.3

Accrued Expenses and Other Current Liabilities | 9 Months Ended
--- | ---
Sep. 30, 2023
Payables and Accruals [Abstract] |
Accrued Expenses and Other Current Liabilities | 9. Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following (in thousands):
|  | September 30, 2023 |  |  | December 31, 2022 |
Accrued clinical study and trial costs |  | $ | 21,832 |  |  | $ | 14,375 |
Accrued compensation and related costs |  |  | 7,931 |  |  |  | 5,945 |
Accrued professional fees |  |  | 1,588 |  |  |  | 1,352 |
Accrued milestone costs |  |  | — |  |  |  | 2,000 |
Other |  |  | 768 |  |  |  | 604 |
Total accrued expenses and other current liabilities |  | $ | 32,119 |  |  | $ | 24,276 |

X
- Definition The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period. + References No definition available. + Details
Name: | us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration